HRT Financial’s Exact Sciences EXAS Stock Holding History

HRT Financial’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,800	Closed	-$536K	–	3396
2025 Q3	$536K	Buy	+9,800	New	+$490K	﹤0.01%	1855
2024 Q2	–	Sell	-27,000	Closed	-$1.86M	–	2459
2024 Q1	$1.86M	Buy	+27,000	New	+$1.71M	0.01%	595
2021 Q2	–	Sell	-2,600	Closed	-$342K	–	3031
2021 Q1	$342K	Buy	+2,600	New	+$356K	﹤0.01%	2029

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

HRT Financial's EXAS Position: Q1 2026 in Review

HRT Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 99,672 shares — an estimated $10.1M sold.

HRT Financial first reported a position in EXAS in Q2 2018 and held it in 13 quarters. The position peaked at $10.1M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

HRT Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 99,672 Exact Sciences shares in Q1 2026, an estimated $10.1M.
HRT Financial first reported a position in Exact Sciences in Q2 2018 and held it in 13 quarters.
HRT Financial's Exact Sciences position peaked at $10.1M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.